IP Library Granted Patent US 9,161,908
Granted Patent B2
US 9,161,908 · App. 14/008,367 · Granted Oct 20, 2015

Pouch containing nicotine in free salt form

Inventor: Per-Gunnar Nilsson (Malmo, SE)
Assignees: TILLCE AB; WM17 Holding AG
A61K9/0056A24B15/16A61K9/006A61K9/009A61K9/145A61K9/1611A61K9/1623A61K9/1635A61K9/1652A61K31/465
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,161,908
App. No.
14/008,367
Granted
Oct 20, 2015
Kind
B2
Abstract

The invention relates to a product for oral delivery of nicotine containing a core comprising a powder of at least one free nicotine salt, at least one pH adjusting agent and at least one filler, and a water insoluble pouch, wherein said pouch is permeable for saliva and therein dissolved parts of the powder, wherein said product upon contact with purified water gives a pH of at least 6. The invention also relates to a method to manufacture such a product.

Claims (27)

1. A product for oral delivery of nicotine containing a core comprising a powder of

a) at least one free nicotine salt

b) at least one pH adjusting agent

c) at least one filler

and a water insoluble pouch, wherein said pouch is permeable for saliva and therein dissolved parts of the powder, wherein said product upon contact with purified water gives a pH of at least 6 and wherein said powder being substantially free from adsorbed and/or absorbed nicotine.

2. The product according to claim 1 , wherein said nicotine salt is water soluble.

3. The product according to claim 1 , wherein said nicotine salt is selected from the group consisting of nicotine hydrochloride, nicotine dihydrochloride, nicotine monotartrate, nicotine bitartrate, nicotine bitartrate dihydrate, nicotine sulphate, nicotine zinc chloride monohydrate and nicotine salicylate, and mixtures thereof.

4. The product according to claim 3 , wherein said nicotine salt is nicotine bitartrate dihydrate.

5. The product according to claim 1 , wherein said pH adjusting agent is selected from the group consisting of carbonates including monocarbonate, bicarbonate and sesquicarbonate, acetates, glycinates, gluconates, borates, glycerophosphates or citrates of alkaline metals or ammonium, phosphate systems including monohydrogenphosphate, dihydrogenphosphate and trihydrogenphosphate, metal hydroxides such as sodium hydroxide and potassium hydroxide, and mixtures thereof.

6. The product according to claim 5 , wherein said pH adjusting agent is sodium bicarbonate or sodium carbonate, and mixtures thereof.

7. The product according to claim 5 , wherein said pH adjusting agent is encapsulated or embedded.

8. The product according to claim 7 , wherein said pH adjusting agent is encapsulated or embedded with a polymer which physically separates the pH adjusting agent from the nicotine salt.

9. The product according to claim 1 , wherein said filler is selected from the group consisting of polysaccharides, polyols, sugars, natural fibres, microcrystalline cellulose, cellulose and cellulose derivatives, and mixtures thereof.

10. The product according to claim 1 , wherein said product comprises at least one filler which is a sweetener or a flavoring agent.

11. The product according to claim 10 wherein said sweetener is selected from the group consisting of mono- di- tri- and polysaccharides, polyols such as mannitol and maltitol, natural and synthetic sweeteners such as sucrose, glucose, dextrose, maltose, fructose, saccharin, aspartame, acesulfame, sucralose, saccharin and cyclamates, and mixtures thereof.

12. The product according to claim 10 wherein said flavoring agent is selected from the group consisting of bergamot, eucalyptus, orange, mandarin, citrus, lemon, peppermint, mint, menthol, liquorice, wintergreen, tobacco, coffee, vanilla, lime, apple, peach, and mixtures thereof.

13. The product according to claim 1 , wherein said pouch is manufactured from material selected from the group consisting of pharmaceutically acceptable membrane materials.

14. The product according to claim 1 , wherein said product comprises nicotine in an amount of from 0.1 to 10 mg per unit dose calculated as nicotine base.

15. The product according to claim 14 , wherein said product comprises nicotine in an amount of 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.0, 8.0 or 9.0 mg per unit dose calculated as nicotine base.

16. The product according to claim 1 , wherein said product comprises from 50 mg to 1000 mg of said powder.

17. The product according to claim 16 , wherein said product comprises 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900 or 950 mg of said powder.

18. A method of making a product comprising the steps of

a) combining ingredients to form a powder, wherein the powder comprises at least one free nicotine salt wherein a substantial portion of the at least one free nicotine salt is not bound, at least one pH adjusting agent and at least one filler;

b) placing the powder in a water insoluble pouch thereby forming a product for oral delivery of nicotine, wherein said pouch is permeable for saliva and therein dissolved parts of the powder, wherein said product upon contact with purified water gives a pH of at least 6.

19. The method according to claim 18 wherein said method comprising the additional steps of encapsulating or embedding the pH adjusting agent.

20. The method according to claim 18 wherein said method comprising the additional step of granulating the powder.

21. The product according to claim 1 , wherein said powder is granulated.

Assignments (7)
MERGER Recorded Aug 18, 2021
From: WM17 HOLDING GMBH
To: WM15 HOLDING GMBH
Reel/Frame 057215/0893 →
MERGER Recorded Aug 18, 2021
From: WM15 HOLDING GMBH; BURGER SÖHNE HOLDING GMBH; HELIX INNOVATIONS INTERNATIONAL GMBH
To: HELIX INNOVATIONS GMBH
Reel/Frame 057318/0964 →
CHANGE OF NAME Recorded Mar 9, 2020
From: WM17 HOLDING AG
To: WM17 HOLDING GMBH
Reel/Frame 052055/0796 →
CHANGE OF ADDRESS Recorded Mar 16, 2017
From: NYZ AB
To: NYZ AB
Reel/Frame 042023/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: TILLCE AB
To: NYZ AB
Reel/Frame 039016/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2014
From: CHILL OF SWEDEN AB
To: TILLCE AB; WM17 HOLDING AG
Reel/Frame 032262/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2014
From: NILSSON, PER-GUNNAR
To: CHILL OF SWEDEN AB
Reel/Frame 032232/0240 →
Priority Claims (1)
SE 1150273 · Mar 29, 2011 · national
Continuity (2)
Provisional Application 61470264 · Mar 31, 2011
Related Publication 20140017286A1 · Jan 16, 2014